Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'HUMAN BLADDER-CANCER' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 89 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Irwin, MS; Kaelin, WG
      Role of the newer p53 family proteins in malignancy

      APOPTOSIS
    2. Chopin, D; Gattegno, B; Cappellen, D; Radvanyi, F
      Oncogenes

      PROGRES EN UROLOGIE
    3. Wieder, J; Freedland, SJ; Pantuck, AJ; Zisman, A; Belldegrun, AS
      Update on gene and immune based therapy for urologic malignancy

      UROLOGIC ONCOLOGY
    4. McGarvey, TW; Meng, RD; Johnson, O; El-Deiry, W; Malkowicz, SB
      Growth inhibitory effect of p21 and p53 containing adenoviruses on transitional cell carcinoma cell lines in vitro and in vivo

      UROLOGIC ONCOLOGY
    5. Vikhanskaya, F; Bani, MR; Borsotti, P; Ghilardi, C; Ceruti, R; Ghisleni, G; Marabese, M; Giavazzi, R; Broggini, M; Taraboletti, G
      p73 overexpression increases VEGF and reduces thrombospondin-1 production:implications for tumor angiogenesis

      ONCOGENE
    6. Liu, L; Cui, X; Sakaguchi, T; Sasaki, M; Suda, T; Hatakeyama, K
      Expression of p73 in colorectal carcinoma: Clinicopathological relevance

      JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
    7. Dominguez, G; Silva, JM; Silva, J; Garcia, JM; Sanchez, A; Navarro, A; Gallego, I; Provencio, M; Espana, P; Bonilla, F
      Wild type p73 overexpression and high-grade malignancy in breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    8. Liu, ML; Taketani, T; Li, RS; Takita, J; Taki, T; Yang, HW; Kawaguchi, H; Ida, K; Matsuo, Y; Hayashi, Y
      Loss of p73 gene expression in lymphoid leukemia cell lines is associated with hypermethylation

      LEUKEMIA RESEARCH
    9. El-Naggar, AK; Lai, SL; Clayman, GL; Mims, B; Lippman, SM; Coombes, M; Luna, MA; Lozano, G
      p73 gene alterations and expression in primary oral and laryngeal squamouscarcinomas

      CARCINOGENESIS
    10. Orlando, C; Gelmini, S; Selli, C; Pazzagli, M
      Telomerase in urological malignancy

      JOURNAL OF UROLOGY
    11. Izes, JK; Dyer, MW; Callum, MG; Bankes, P; Libertino, JA; McCaffrey, JA
      CA 125 as a marker of tumor activity in advanced urothelial malignancy

      JOURNAL OF UROLOGY
    12. Mendelsohn, J; Dinney, CPN
      The Willet F. Whitmore, Jr., lectureship: Blockade of epidermal growth factor receptors as anticancer therapy

      JOURNAL OF UROLOGY
    13. Vikhanskaya, F; Marchini, S; Marabese, M; Galliera, E; Broggini, M
      p73 alpha overexpression is associated with resistance to treatment with DNA-damaging agents in a human ovarian cancer cell line

      CANCER RESEARCH
    14. Rusnak, DW; Affleck, K; Cockerill, SG; Stubberfield, C; Harris, R; Page, M; Smith, KJ; Guntrip, SB; Carter, MC; Shaw, RJ; Jowett, A; Stables, J; Topley, P; Wood, ER; Brignola, PS; Kadwell, SH; Reep, BR; Mullin, RJ; Alligood, KJ; Keith, BR; Crosby, RM; Murray, DM; Knight, WB; Gilmer, TM; Lackey, K
      The characterization of novel, dual ErbB-2/EGFR, tyrosine kinase inhibitors: Potential therapy for cancer

      CANCER RESEARCH
    15. Liu, BCS; LaRose, I; Weinstein, LJ; Ahn, M; Weinstein, MH; Richie, JP
      Expression of telomerase subunits in normal and neoplastic prostate epithelial cells isolated by laser capture microdissection

      CANCER
    16. Brandstetter, T; Ninci, E; Bettendorf, H; Perewusnyk, G; Stolte, J; Herchenbach, D; Sellin, D; Wagner, E; Kochli, OR; Bauknecht, T
      Granulocyte colony-stimulating factor (G-CSF) receptor gene expression of ovarian carcinoma does not correlate with G-CSF caused cell proliferation

      CANCER
    17. Watanabe, T; Shinohara, N; Moriya, K; Sazawa, A; Kobayashi, Y; Ogiso, Y; Takiguchi, M; Yasuda, J; Koyanagi, T; Kuzumaki, N; Hashimoto, A
      Significance of the Grb2 and Son of sevenless (Sos) proteins in human bladder cancer cell lines

      IUBMB LIFE
    18. Jefferson, KP; Persad, RA; Holly, JMP
      Apoptosis and its relevance to urologists

      BJU INTERNATIONAL

    19. Gene therapy: Principles and applications in urology

      PROGRES EN UROLOGIE
    20. Kang, MJ; Park, BJ; Byun, DS; Park, JI; Kim, HJ; Park, JH; Chi, SG
      Loss of imprinting and elevated expression of wild-type p73 in human gastric adenocarcinoma

      CLINICAL CANCER RESEARCH
    21. Huang, LL; Pardee, AB
      Suberoylanilide hydroxamic acid as a potential therapeutic agent for humanbreast cancer treatment

      MOLECULAR MEDICINE
    22. Aben, KKH; Witjes, JA; van Dijck, JAAM; Schalken, JA; Verbeek, ALM; Kiemeney, LALM
      Lower incidence of urothelial cell carcinoma due to the concept of a clonal origin

      EUROPEAN JOURNAL OF CANCER
    23. Watanabe, T; Shinohara, N; Sazawa, A; Harabayashi, T; Ogiso, Y; Koyanagi, T; Takiguchi, M; Hashimoto, A; Kuzumaki, N; Yamashita, M; Tanaka, M; Grossman, HB; Benedict, WF
      An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies

      CANCER GENE THERAPY
    24. Marin, MC; Kaelin, WG
      p63 and p73: Old members of a new family

      BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
    25. Hirano, Y; Kageyama, S; Ushiyama, T; Suzuki, K; Fujita, K
      Thymidine phosphorylase activity in transitional cell cancer: Relation to histological parameters and chemosensitivity to fluorouracil-related drugs

      ANTICANCER RESEARCH
    26. Sengelov, L; Christensen, M; von der Maase, H; Horn, T; Marcussen, N; Kamby, C; Orntoft, T
      Loss of heterozygosity at 1p, 8p, 10p, 13q, and 17p in advanced urothelialcancer and lack of relation to chemotherapy response and outcome

      CANCER GENETICS AND CYTOGENETICS
    27. Cordon-Cardo, C; Cote, RJ; Sauter, G
      Genetic and molecular markers of urothelial premalignancy and malignancy

      SCANDINAVIAN JOURNAL OF UROLOGY AND NEPHROLOGY
    28. De Kok, JB; Schalken, JA; Aalders, TW; Ruers, TJM; Willems, HL; Swinkels, DW
      Quantitative measurement of telomerase reverse transcriptase (hTERT) mRNA in urothelial cell carcinomas

      INTERNATIONAL JOURNAL OF CANCER
    29. Arai, Y; Yajima, T; Yagihashi, A; Kobayashi, D; Kameshima, H; Sasaki, M; Tanaka, K; Kuwajima, K; Miyao, N; Tsukamoto, T; Watanabe, N
      Limitations of urinary telomerase activity measurement in urothelial cancer

      CLINICA CHIMICA ACTA
    30. Knowles, MA
      The genetics of transitional cell carcinoma: progress and potential clinical application

      BJU INTERNATIONAL
    31. Perrotte, P; Matsumoto, T; Inoue, K; Kuniyasu, H; Eve, BY; Hicklin, DJ; Radinsky, R; Dinney, CPN
      Anti-epidermal growth factor receptor antibody C225 inhibits angiogenesis in human transitional cell carcinoma growing orthotopically in nude mice

      CLINICAL CANCER RESEARCH
    32. Friess, H; Fukuda, A; Tang, WH; Eichenberger, A; Furlan, N; Zimmermann, A; Korc, M; Buchler, MW
      Concomitant analysis of the epidermal growth factor receptor family in esophageal cancer: Overexpression of epidermal growth factor receptor mRNA butnot of c-erbB-2 and c-erbB-3

      WORLD JOURNAL OF SURGERY
    33. Waliszewski, P; Waliszewska, M; Gordon, N; Hurst, RE; Benbrook, DM; Dhar, A; Hemstreet, GP
      Retinoid signaling in immortalized and carcinoma-derived human uroepithelial cells

      MOLECULAR AND CELLULAR ENDOCRINOLOGY
    34. Cole, C; Foster, AJ; Freeman, S; Jaffar, M; Murray, PE; Stratford, IJ
      The role of thymidine phosphorylase/PD-ECGF in cancer chemotherapy: a chemical perspective

      ANTI-CANCER DRUG DESIGN
    35. Bernues, M; Casadevall, C; Caballin, MR; Miro, R; Ejarque, MJ; Chechile, G; Gelabert, A; Egozcue, J
      Study of allelic losses on 3p, 6q, and 17p in human urothelial cancer

      CANCER GENETICS AND CYTOGENETICS
    36. Liu, YM; Wang, ZP; Zhang, ZH; Zhang, Q; Cheng, YR; Xu, KC; Wang, LF
      Synthesis, characterization and antitumor activity of ternary complexes ofall-trans retinoic acid with rare earth metals

      JOURNAL OF COORDINATION CHEMISTRY
    37. Maitra, A; Wistuba, II; Gibbons, D; Gazdar, AF; Albores-Saavedra, J
      Allelic losses at chromosome 3p are seen in human papilloma virus 16 associated transitional cell carcinoma of the cervix

      GYNECOLOGIC ONCOLOGY
    38. Izadifar, V; de Boer, WI; Muscatelli-Groux, B; Maille, P; van der Kwast, TH; Chopin, DK
      Expression of transforming growth factor beta 1 and its receptors in normal human urothelium and human transitional cell carcinomas

      HUMAN PATHOLOGY
    39. Rein, T; Kobayashi, T; Malott, M; Leffak, M; DePamphilis, ML
      DNA methylation at mammalian replication origins

      JOURNAL OF BIOLOGICAL CHEMISTRY
    40. Miyamoto, H; Miyagi, Y; Ishikawa, T; Ichikawa, Y; Hosaka, M; Kubota, Y
      DNA polymerase beta gene mutation in human breast cancer

      INTERNATIONAL JOURNAL OF CANCER
    41. Lange, N; Jichlinski, P; Zellweger, M; Forrer, M; Marti, A; Guillou, L; Kucera, P; Wagnieres, G; van den Bergh, H
      Photodetection of early human bladder cancer based on the fluorescence of 5-aminolaevulinic acid hexylester-induced protoporphyrin IX: a pilot study

      BRITISH JOURNAL OF CANCER
    42. VIETEN L; BELAIR CD; SAVELIEVA L; JULICHER K; BROCKER F; BARDENHEUER W; SCHUTTE J; OPALKA B; REZNIKOFF CA
      MINIMAL DELETION OF 3P13-]14.2 ASSOCIATED WITH IMMORTALIZATION OF HUMAN UROEPITHELIAL CELLS

      Genes, chromosomes & cancer
    43. CHRISTENSEN ME
      THE EGF RECEPTOR SYSTEM IN HEAD AND NECK CARCINOMAS AND NORMAL-TISSUES - IMMUNOHISTOCHEMICAL AND QUANTITATIVE STUDIES

      Danish medical bulletin
    44. YEAGER TR; DEVRIES S; JARRARD DF; KAO CH; NAKADA SY; MOON TD; BRUSKEWITZ R; STADLER WM; MEISNER LF; GILCHRIST KW; NEWTON MA; WALDMAN FM; REZNIKOFF CA
      OVERCOMING CELLULAR SENESCENCE IN HUMAN CANCER PATHOGENESIS

      Genes & development
    45. BADAWI AF
      O-6-METHYLGUANINE AND O-6-METHYLGUANINE-DNA METHYLTRANSFERASE ACTIVITY IN TISSUES OF BDF-1 MICE TREATED WITH ANTIPARASITIC DRUGS

      Toxicology letters
    46. OKAMOTO M; HATTORI K; FUJIMOTO K; TANAKA Y; GLOOSBY CL; OYASU R
      ANTISENSE RNA-MEDIATED REDUCTION OF P53 INDUCES MALIGNANT PHENOTYPE IN NONTUMORIGENIC RAT UROTHELIAL CELLS

      Carcinogenesis
    47. KONOMOTO T; FUKUDA T; HAYASHI K; KUMAZAWA J; TSUNEYOSHI M
      LEIOMYOSARCOMA IN SOFT-TISSUE - EXAMINATION OF P53 STATUS AND CELL PROLIFERATING FACTORS IN DIFFERENT LOCATIONS

      Human pathology
    48. CLASEN S; SCHULZ WA; GERHARZ CD; GRIMM MO; CHRISTOPH F; SCHMITZDRAGER BJ
      FREQUENT AND HETEROGENOUS EXPRESSION OF CYCLIN-DEPENDENT KINASE INHIBITOR WAF1 P21 PROTEIN AND MESSENGER-RNA IN UROTHELIAL CARCINOMA/

      British Journal of Cancer
    49. VANBRUSSEL JP; VANSTEENBRUGGE GJ; MICKISCH GHJ
      MECHANISMS OF AND STRATEGIES TO OVERCOME MULTIDRUG-RESISTANCE OF GENITOURINARY TUMORS

      Aktuelle Urologie
    50. KISSIL JL; FEINSTEIN E; COHEN O; JONES PA; TSAI YC; KNOWLES MA; EYDMANN ME; KIMCHI A
      DAP-KINASE LOSS OF EXPRESSION IN VARIOUS CARCINOMA AND B-CELL LYMPHOMA CELL-LINES - POSSIBLE IMPLICATIONS FOR ROLE AS TUMOR-SUPPRESSOR GENE

      Oncogene
    51. AKAO T; KAKEHI Y; ITOH N; OZDEMIR E; SHIMIZU T; TACHIBANA A; SASAKI MS; YOSHIDA O
      A HIGH PREVALENCE OF FUNCTIONAL INACTIVATION BY METHYLATION MODIFICATION OF P16(INK4A) CDKN2/MTS1 GENE IN PRIMARY UROTHELIAL CANCERS/

      Japanese journal of cancer research
    52. OLIVA MR; RIPOLL F; MUNIZ P; IRADI A; TRULLENQUE R; VALLS V; DREHMER E; SAEZ GT
      GENETIC ALTERATIONS AND OXIDATIVE-METABOLISM IN SPORADIC COLORECTAL TUMORS FROM A SPANISH COMMUNITY

      Molecular carcinogenesis
    53. GOTO K; KONOMOTO T; HAYASHI K; KINUKAWA N; NAITO S; KUMAZAWA J; TSUNEYOSHI M
      P53 MUTATIONS IN MULTIPLE UROTHELIAL CARCINOMAS - A MOLECULAR ANALYSIS OF THE DEVELOPMENT OF MULTIPLE CARCINOMAS

      Modern pathology
    54. SAKANO S; SHIMABUKURO T; OHMOTO Y; NAITO K
      CYTOKINE-MEDIATED ANTITUMOR EFFECT OF OK-432 ON URINARY-BLADDER TUMOR-CELLS IN-VITRO

      Urological research
    55. YOSHIDA K; HOSOYA Y; SUMI S; HONDA M; MORIGUCHI H; YANO M; UEDA Y
      STUDIES OF THE EXPRESSION OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN HUMAN RENAL-CELL CARCINOMA - A COMPARISON OF IMMUNOHISTOCHEMICAL METHOD VERSUS LIGAND-BINDING ASSAY

      Oncology
    56. OZDEMIR E; KAKEHI Y; OKUNO H; HABUCHI T; OKADA Y; YOSHIDA O
      STRONG CORRELATION OF BASEMENT-MEMBRANE DEGRADATION WITH P53 INACTIVATION AND OR MDM2 OVEREXPRESSION IN SUPERFICIAL UROTHELIAL CARCINOMAS/

      The Journal of urology
    57. MIYAKE H; YOSHIMURA K; HARA I; ETO H; ARAKAWA S; KAMIDONO S
      BASIC FIBROBLAST GROWTH-FACTOR REGULATES MATRIX METALLOPROTEINASES PRODUCTION AND IN-VITRO INVASIVENESS IN HUMAN BLADDER-CANCER CELL-LINES

      The Journal of urology
    58. DORKIN TJ; ROBSON CN; NEAL DE
      THE MOLECULAR PATHOLOGY OF UROLOGICAL MALIGNANCIES

      Journal of pathology
    59. GRESCHNER M; SIEGSMUND M; ALKEN P
      GENETIC-BASIS OF HEREDITARY UROLOGICAL DI SEASES .2. MALIGNANT DISEASES AND SYNDROMES

      Aktuelle Urologie
    60. NELSON E
      LABORATORY PROBING OF ONCOGENES FROM HUMAN LIQUID AND SOLID SPECIMENSAS MARKERS OF EXPOSURE TO TOXICANTS

      Critical reviews in toxicology
    61. MALKOWICZ SB; TOMASZEWSKI JE; LINNENBACH AJ; CANGIANO TA; MARUTA Y; MCGARVEY TW
      NOVEL P21(WAF1 CIP1) MUTATIONS IN SUPERFICIAL AND INVASIVE TRANSITIONAL-CELL CARCINOMAS/

      Oncogene
    62. YEN WC; SCHMITTGEN T; AU JLS
      DIFFERENT PH DEPENDENCY OF MITOMYCIN-C ACTIVITY IN MONOLAYER AND 3-DIMENSIONAL CULTURES

      Pharmaceutical research
    63. PRESTI JC; MOCH H; REUTER VE; CORDONCARDO C; WALDMAN FM
      RENAL-CELL CARCINOMA GENETIC-ANALYSIS BY COMPARATIVE GENOMIC HYBRIDIZATION AND RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM ANALYSIS

      The Journal of urology
    64. PODDIGHE PJ; BRINGUIER PP; VALLINGA M; SCHALKEN JA; RAMAEKERS FCS; HOPMAN AHN
      LOSS OF CHROMOSOME-9 IN TISSUE-SECTIONS OF TRANSITIONAL-CELL CARCINOMAS AS DETECTED BY INTERPHASE CYTOGENETICS - A COMPARISON WITH RFLP ANALYSIS

      Journal of pathology
    65. RADINSKY R; RISIN S; FAN D; DONG ZY; BIELENBERG D; BUCANA CD; FIDLER IJ
      LEVEL AND FUNCTION OF EPIDERMAL GROWTH-FACTOR RECEPTOR PREDICT THE METASTATIC POTENTIAL OF HUMAN COLON-CARCINOMA CELLS

      Clinical cancer research
    66. SALOMON DS; BRANDT R; CIARDIELLO F; NORMANNO N
      EPIDERMAL GROWTH FACTOR-RELATED PEPTIDES AND THEIR RECEPTORS IN HUMANMALIGNANCIES

      Critical reviews in oncology/hematology
    67. ITO H; KOTAKE T; MASAI M; MIZUTA T; ADACHI M
      ESTABLISHMENT OF HUMAN BLADDER-CANCER CELL-LINE (HAMT-1) AND LONG-TERM SUBCULTURE IN NUDE-MICE

      Oncology Reports
    68. AHSAN H; NEUGUT AI; BRUCE JN
      ASSOCIATION OF MALIGNANT BRAIN-TUMORS AND CANCERS OF OTHER SITES

      Journal of clinical oncology
    69. SCHON MP; BLUMEPEYTAVI U; SCHON M; ORFANOS CE
      THE HUMAN HAIR FOLLICLE - GLYCOPROTEIN-RELATED ANTIGENIC PROFILE OF DISTINCT KERATINOCYTE POPULATIONS IN-VIVO AND THEIR ALTERATIONS IN-VITRO

      Archives of dermatological research
    70. RADINSKY R
      MODULATION OF TUMOR-CELL GENE-EXPRESSION AND PHENOTYPE BY THE ORGAN-SPECIFIC METASTATIC ENVIRONMENT

      Cancer metastasis reviews
    71. MURAOKA K; NABESHIMA K; KATAOKA H; KISHI J; KOONO M
      ESTABLISHMENT OF A NEW HUMAN URINARY-BLADDER MIXED CARCINOMA CELL-LINE UMK-1 AND ITS CELL-DENSITY-DEPENDENT SECRETION OF GELATINASES AND TISSUE INHIBITOR OF METALLOPROTEINASE-1

      Urologia internationalis
    72. SCHON MP; ORFANOS CE
      TRANSFORMATION OF HUMAN KERATINOCYTES IS CHARACTERIZED BY QUANTITATIVE AND QUALITATIVE ALTERATIONS OF THE T-16 ANTIGEN (TROP-2, MOV-16)

      International journal of cancer
    73. JAEGER TM; FORSTER S; AUFENANGER J; MOORE DH; RASSWEILER J; ALKEN P
      ACTIVITY OF GLUTATHIONE-PEROXIDASE IN HUM AN BLADDER-CANCER

      Aktuelle Urologie
    74. REZNIKOFF CA; BELAIR C; SAVELIEVA E; ZHAI Y; PFEIFER K; YEAGER T; THOMPSON KJ; DEVRIES S; BINDLEY C; NEWTON MA; SEKHON G; WALDMAN F
      LONG-TERM GENOME STABILITY AND MINIMAL GENOTYPIC AND PHENOTYPIC ALTERATIONS IN HPV16 E7-, BUT NOT E6-, IMMORTALIZED HUMAN UROEPITHELIAL CELLS

      Genes & development
    75. SHAMEEM IA; KURISU H; MATSUYAMA H; SHIMABUKURO T; NAITO K
      DIRECT AND INDIRECT EFFECTS OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR ON IN-VITRO COLONY FORMATION OF HUMAN BLADDER-CANCERCELLS

      Cancer immunology and immunotherapy
    76. STROHMEYER T
      UROTHELIAL CARCINOMA - FUNDAMENTAL CYTOGE NETIC AND MOLECULAR BIOLOGICAL ASPECTS

      Der Urologe
    77. KAWASAKI T; TOMITA Y; WATANABE R; TANIKAWA T; KUMANISHI T; SATO S
      MESSENGER-RNA AND PROTEIN EXPRESSION OF P53 MUTATIONS IN HUMAN BLADDER-CANCER CELL-LINES

      Cancer letters
    78. ANGELL M; KASSIRER J
      CLINICAL RESEARCH - WHAT SHOULD THE PUBLIC BELIEVE (REPRINTED FROM N-ENGL-J-MED, VOL 331, PG 189-90, 1994)

      Nutrition reviews
    79. ANGELL M; KASSIRER JP
      CLINICAL RESEARCH - WHAT SHOULD THE PUBLIC BELIEVE

      The New England journal of medicine
    80. STROHMEYER TG; SLAMON DJ
      PROTOONCOGENES AND TUMOR-SUPPRESSOR GENES IN HUMAN UROLOGICAL MALIGNANCIES

      The Journal of urology
    81. RODRIGUEZ E; SREEKANTAIAH C; CHAGANTI RSK
      GENETIC CHANGES IN EPITHELIAL SOLID NEOPLASIA

      Cancer research
    82. LATRES E; DROBNJAK M; POLLACK D; OLIVA MR; RAMOS M; KARPEH M; WOODRUFF JM; CORDONCARDO C
      CHROMOSOME-17 ABNORMALITIES AND TP53 MUTATIONS IN ADULT SOFT-TISSUE SARCOMAS

      The American journal of pathology
    83. HABUCHI T; KINOSHITA H; YAMADA H; KAKEHI Y; OGAWA O; WU WJ; TAKAHASHI R; SUGIYAMA T; YOSHIDA O
      ONCOGENE AMPLIFICATION IN UROTHELIAL CANCERS WITH P53 GENE MUTATION OR MDM2 AMPLIFICATION

      Journal of the National Cancer Institute
    84. LINNENBACH AJ; PRESSLER LB; SENG BA; KIMMEL BS; TOMASZEWSKI JE; MALKOWICZ SB
      CHARACTERIZATION OF CHROMOSOME-9 DELETIONS IN TRANSITIONAL-CELL CARCINOMA BY MICROSATELLITE ASSAY

      Human molecular genetics
    85. CHOW NH; TZAI TS; LIN SN; CHAN SH; TANG MJ
      REAPPRAISAL OF THE BIOLOGICAL ROLE OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN TRANSITIONAL-CELL CARCINOMA

      European urology
    86. MACKINNON WB; DYNE M; HANCOCK R; GRANT AJ; RUSSELL P; MOUNTFORD CE
      MALIGNANCY-RELATED CHARACTERISTICS OF WILD-TYPE AND DRUG-RESISTANT CHINESE-HAMSTER OVARY CELLS

      Pathology
    87. PRESTI JC; REUTER VE; CORDONCARDO C; MAZUMDAR M; FAIR WR; JHANWAR SC
      ALLELIC DELETIONS IN RENAL TUMORS - HISTOPATHOLOGICAL CORRELATIONS

      Cancer research
    88. GLEAVE ME; HSIEH JT; WU HC; HONG SJ; ZHAU HE; GUTHRIE PD; CHUNG LWK
      EPIDERMAL GROWTH-FACTOR RECEPTOR-MEDIATED AUTOCRINE AND PARACRINE STIMULATION OF HUMAN TRANSITIONAL-CELL CARCINOMA

      Cancer research
    89. CHRISTENSEN B; HANSEN C; DEBIECRYCHTER M; KIELER J; OTTENSEN S; SCHMIDT J
      IDENTITY OF TUMORIGENIC HUMAN UROTHELIAL CELL-LINES AND SPONTANEOUSLYTRANSFORMED SUBLINES

      British Journal of Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 03/06/20 alle ore 21:03:31